Interlocking buttress material retention system

Information

  • Patent Grant
  • 9016543
  • Patent Number
    9,016,543
  • Date Filed
    Monday, December 2, 2013
    10 years ago
  • Date Issued
    Tuesday, April 28, 2015
    9 years ago
Abstract
A surgical stapler is provided having a pair of jaws including a staple containing cartridge and an anvil. Buttress material is releasable affixed to the staple containing cartridge and the anvil. One of the jaws includes a pair of longitudinal projections at a first end of the jaw and configured to frictionally engage corresponding slots in a first end the buttress material. One of the jaws includes a post at a second end of the jaw. The buttress material includes a hole in a second end of the buttress material for receipt of the post.
Description
BACKGROUND

1. Technical Field


The present disclosure relates to attachment systems for staple line buttress materials. More particularly, the present disclosure relates to systems and methods of temporarily attaching staple line buttress materials to an anvil and staple containing cartridge of a surgical stapling instrument.


2. Background of Related Art


Surgical stapling instruments, or “stapling devices”, are employed by surgeons to sequentially or simultaneously apply one or more rows of fasteners, e.g., staples or two-part fasteners, to body tissue for the purpose of joining segments of body tissue together. Such devices generally include of a pair of jaws or finger-like structures between which the body tissue to be joined is placed. When the stapling device is actuated, or “fired”, longitudinally moving firing bars contact staple drive members in one of the jaws. The staple drive members push the surgical staples through the body tissue and into an anvil in the opposite jaw which crimps the staples closed. If tissue is to be removed or separated, a knife blade can be provided in the jaws of the device to cut the tissue between the lines of staples.


When stapling relatively thin or fragile tissues, it is important to effectively seal the staple line against air or fluid leakage. Additionally, it is often necessary to reinforce the staple line against the tissue to prevent tears in the tissue or pulling of the staples through the tissue. One method of preventing tears or pull through involves the placement of a biocompatible fabric reinforcing material, or “buttress” material, between the staple and the underlying tissue. In this method, a layer of buttress material is placed against the tissue and the tissue is stapled in conventional manner. In more recent methods, the buttress material is positioned on the stapling instrument itself prior to stapling the tissue. An exemplary example of this is disclosed in U.S. Pat. No. 5,542,594 to McKean et al. In McKean et al., a tube of buttress material is slipped over the jaw of the stapler. The stapler is then actuated to staple the subject tissue and secure the buttress material between the tissue and staple line to reinforce the tissue and staple line.


Some novel surgical staplers utilize fasteners or clips to temporarily connect buttress material to the jaws of the staplers. However, in some instances, it would be desirable to mold or machine structure into the jaws themselves to facilitate attachment of correspondingly structured buttress materials. It would be further desirable to provide such structure in a manner which does not interfere with the operation of a knife blade associated with the jaws.


SUMMARY

There is disclosed a surgical stapler having a pair of jaws including a staple cartridge and an anvil. At least one of the jaws includes at least two longitudinally extending projections positioned at a first end of the first jaw. The surgical stapler also has a staple line buttress material releasably affixed to the at least one jaw and including recesses for receipt of the at least two projections. In one embodiment each of the at least two projections includes a neck portion and a bulbous portion. In an alternative embodiment, each of the at least two projections is relatively straight. The at least one jaw includes a longitudinally extending knife slot, the at least two projections being separated by the knife slot.


In a further embodiment, the at least one jaw includes two sets of the at least two projections and the at least one jaw includes a longitudinally extending knife slot. The knife slot separates the two sets of the at least two projections.


In particular embodiments, the at least one jaw includes a post at a second end and the buttress material includes a hole for receipt of the post. In a first version, the post is split to allow passage of a knife therebetween, whereas in a second version the post is solid.


In a specific embodiment, the post forms a mushroom shaped protrusion having a cap and the cap defines a flange for engagement with a portion of the buttress material.


In another embodiment the at least one jaw includes a pair of posts and the buttress material includes a pair of holes for receipt of the pair of posts. Each post of the pair of posts is positioned adjacent an outside edge of the buttress material. The at least one jaw also includes a longitudinally extending slot such that the pair of posts are separated by the slot.


In a particular embodiment, the at least one jaw includes a longitudinally extending slot and the post is positioned distally of a distal end of the slot and the buttress material has a hole for receipt of the post. The buttress material further includes a longitudinal slit extending through the area of the buttress material defining the hole.





DESCRIPTION OF THE DRAWINGS

Various embodiments of the presently disclosed interlocking buttress retention systems are disclosed herein with reference to the drawings, wherein:



FIG. 1 is a perspective view of a surgical stapling instrument incorporating embodiments of retention systems for attachment of staple line buttress materials to an anvil and staple containing cartridge of the surgical stapling instrument;



FIG. 2 is a enlarged perspective view of the distal end of the surgical stapling instrument of FIG. 1;



FIG. 3 is a perspective view, with parts separated, of one embodiment of an anvil and buttress material retention system;



FIG. 4 is a perspective view of the assembled anvil buttress material retention system;



FIG. 5 is a top view of the distal end of the anvil buttress material retention system of FIG. 4;



FIG. 6 is a cross-sectional view taken along line 6-6 of FIG. 4;



FIG. 7 is a perspective view, with parts separated, of the proximal end of the anvil buttress retention system of FIG. 4;



FIG. 8 is a cross-sectional view taken along line 8-8 of FIG. 7;



FIG. 9 is a perspective view, with parts separated, of an alternative embodiment of the proximal end of an anvil buttress retention system;



FIG. 10 is a cross-sectional view taken along line 10-10 of FIG. 9;



FIG. 11 is a perspective view, with parts separated, of one embodiment of a staple containing cartridge and buttress material retention system;



FIG. 12 is a perspective view of the assembled cartridge buttress retention system of FIG. 11;



FIG. 13 is a top view of the proximal end of the cartridge buttress retention system of FIG. 12;



FIG. 14 is a top view of an alternative embodiment of a proximal end of a cartridge buttress retention system;



FIG. 15 is a cross sectional view taken along line 15-15 of FIG. 12;



FIG. 16 is a perspective view, with parts separated, of the distal end of the cartridge buttress retentions system of FIG. 12;



FIG. 17 is a cross-sectional view taken along line 17-17 of FIG. 16;



FIG. 18 is a perspective view, with parts separated, of an alternative embodiment of a distal end of cartridge buttress retention system;



FIG. 19 is a cross-sectional view taken along line 19-19 of FIG. 18;



FIG. 20 is a perspective view of, with parts separated, of a further alternative embodiment of a distal end of a cartridge buttress retention system;



FIG. 21 is a cross-sectional view taken along line 21-21 of FIG. 20;



FIG. 22 is perspective view of the distal end of the surgical stapling instrument of FIG. 1 positioned about a tissue section;



FIG. 23 is side view, partially shown in section, of the distal end of the surgical stapling instrument positioned about the tissue section;



FIG. 24 is a side view, partially shown in section, during initial actuation of the surgical stapling instrument of FIG. 1;



FIG. 25 is a perspective view of a stapled and divided tissue section; and



FIG. 26 is a cross-sectional view taken along line 26-26 of FIG. 25.





DETAILED DESCRIPTION OF EMBODIMENTS

Embodiments of the presently disclosed interlocking buttress material retention systems for use with surgical stapling instruments will now be described in detail with reference to the drawings wherein like numerals designate identical or corresponding elements in each of the several views. As is common in the art, the term ‘proximal” refers to that part or component closer to the user or operator, i.e. surgeon or physician, while the term “distal” refers to that part or component further away from the user.


Referring now to FIG. 1, there is disclosed a linear surgical stapling instrument or surgical stapler 10 for use in stapling tissue and applying layers of buttress material between the staples and underlying tissue. An exemplary example of this type of surgical stapling instrument is disclosed in U.S. Pat. No. 7,128,253, the entire disclosure of which is incorporated by reference herein. Surgical stapler 10 generally includes a handle 12 having an elongate tubular member 14 extending distally from handle 12. A jaw assembly 16 is mounted on a distal end 18 of elongate tubular member 14. Jaw assembly 16 includes a staple clinching anvil 20 and a staple containing cartridge or staple cartridge 22. Staple cartridge 22 may be permanently affixed to elongate tubular member 14 or may be detachable and thus replaceable with a new staple cartridge 22. Staple clinching anvil 20 is movably mounted on distal end 18 of elongate tubular member 14 and is movable between an open position spaced apart from staple cartridge 22 to a closed position substantially adjacent staple cartridge 22.


Staple clinching anvil 20 is provided with a layer of anvil buttress material 24 and staple cartridge 22 is provided with a layer of cartridge buttress material 26 in the manners described in more detail hereinbelow. An anvil buttress retention system 28 is incorporated into anvil 20 and anvil buttress material 24 and is provided to releasably secure anvil buttress material 24 to staple clinching anvil 20. Likewise, a cartridge buttress retention system 30 incorporated into staple cartridge 22 and cartridge buttress material 26 and is provided to releasably secure cartridge buttress material 26 to staple cartridge 22. Anvil buttress material 24 and cartridge buttress material 26 are provided to reinforce and seal staple lines applied to tissue by surgical stapler 10.


Anvil buttress retention system 28 and cartridge buttress retention system 30 are particularly configured to allow the respective buttress materials to be localized on inwardly facing surfaces of anvil 20 and staple cartridge 22 in order to facilitate passage of surgical stapler 10 into the body of a patient without risk of tearing or wrinkling of the respective buttress materials as surgical stapler 10 is inserted into and manipulated within the body of a patient.


Surgical stapler 10 further includes a trigger 32 movably mounted on handle 12. Actuation of trigger 32 initially operates to move anvil 20 from the open to the closed position relative to staple cartridge 22 and subsequently actuate surgical stapler 10 to apply lines of staples to tissue. In order to properly orient jaw assembly 16 relative to the tissue to be stapled, surgical stapler 10 is additionally provided with a rotation knob 34 mounted on handle 12. Rotation of rotation knob 34 relative to handle 12 rotates elongate tubular member 14 and jaw assembly 16 relative to handle 12 so as to properly orient jaw assembly 16 relative to the tissue to be stapled.


Referring to FIGS. 1 and. 2, a driver 36 is provided to move anvil 20 between the open and closed positions relative to staple cartridge 22. Driver 36 moves between a longitudinal slot 38 formed in anvil 20. A knife blade (not shown) is associated with driver 32 to cut tissue captured between anvil 20 and staple cartridge 22 as driver 36 passes through slot 38.


Referring to FIG. 3, in order to move anvil 20 between the open and closed positions, anvil 20 includes a proximal, angled or sloped edge 40 configured to be engaged by driver 36 in order to cam anvil 20 to the closed position. Slot 38 extends distally from sloped edge 40 and terminates in a transverse slot 42 which is configured to capture driver 36 upon complete actuation of surgical stapler 10 to prevent any further actuation of surgical stapler 10. In order to secure staples provided by staple cartridge 22 about the tissues and buttress materials, anvil 20 is provided with longitudinally extending rows of staple clinching pockets 44 located on either side of longitudinal slot 38.


Referring still to FIG. 3, anvil buttress retention system 28, incorporated into anvil 20 and anvil buttress material 24, will now be described. Anvil buttress material 24, as well as cartridge buttress material 26. The buttress material for the staple cartridge 22 and/or anvil 20 may be made from any biocompatible natural or synthetic material. The material from which the buttress material is formed may be bioabsorbable or non-bioabsorbable. It should of course be understood that any combination of natural, synthetic, bioabsorbable and non-bioabsorbable materials may be used to form the buttress material.


Some non-limiting examples of materials from which the buttress material may be made include but are not limited to poly(lactic acid), poly(glycolic acid), poly(hydroxybutyrate), poly(phosphazine), polyesters, polyethylene glycols, polyethylene oxides, polyacrylamides, polyhydroxyethylmethylacrylate, polyvinylpyrrolidone, polyvinyl alcohols, polyacrylic acid, polyacetate, polycaprolactone, polypropylene, aliphatic polyesters, glycerols, poly(amino acids), copoly(ether-esters), polyalkylene oxalates, polyamides, poly(iminocarbonates), polyalkylene oxalates, polyoxaesters, polyorthoesters, polyphosphazenes and copolymers, block copolymers, homopolymers, blends and combinations thereof.


In embodiments, natural biological polymers are used in forming the buttress material. Suitable natural biological polymers include, but are not limited to, collagen, gelatin, fibrin, fibrinogen, elastin, keratin, albumin, hydroxyethyl cellulose, cellulose, hydroxypropyl cellulose, carboxyethyl cellulose, chitan, chitosan, and combinations thereof. In addition, the natural biological polymers may be combined with any of the other polymeric materials described herein to produce the buttress material.


The buttress material may be porous or non-porous, or combinations of porous and non-porous layers. Where the buttress material is non-porous, buttress material may retard or prevent tissue ingrowth from surrounding tissues thereby acting as an adhesion barrier and preventing the formation of unwanted scar tissue. Thus, in embodiments, the buttress material possesses anti-adhesion properties. Techniques for forming non-porous layers from such materials are within the purview of those skilled in the art and include, for example, casting, molding and the like.


In embodiments, the buttress material is porous and possesses hemostatic properties. Where the buttress material is porous, it has openings or pores over at least a portion of a surface thereof. Suitable materials for forming the porous layer include, but are not limited to foams (e.g., open or closed cell foams). In embodiments, the pores may be in sufficient number and size so as to interconnect across the entire thickness of the porous layer. In other embodiments, the pores do not interconnect across the entire thickness of the porous layer. In yet other embodiments, the pores do not extend across the entire thickness of the porous layer, but rather are present at a portion of the surface thereof. In embodiments, the openings or pores are located on a portion of the surface of the porous layer, with other portions of the porous layer having a non-porous texture. Those skilled in the art reading the present disclosure will envision other pore distribution patterns and configurations for the porous layer.


Where the buttress material is porous, the pores may be formed using any method suitable to forming a foam or sponge including, but not limited to the lyophilization or freeze-drying of a composition. Suitable techniques for making foams are within the purview of those skilled in the art. Porous buttress materials can be at least 0.2 cm thick, in embodiments from about 0.3 to about 1.5 cm thick. Porous buttress materials can have a density of not more than about 75 mg/cm2 and, in embodiments below about 20 mg/cm2. The size of the pores in the porous buttress materials can be from about 20 μm to about 300 μm, in embodiments from about 100 μm to about 200 μm.


The buttress material may also include a reinforcement member. The reinforcement member may be associated with a porous or non-porous layer or may be positioned between a non-porous layer and a porous layer of the buttress material. Alternatively, the reinforcement member may be positioned entirely within one or more of the individual layers (i.e., embedded within the porous layer, the non-porous layer, or both) of the buttress material. It is also envisioned that the reinforcement member may be positioned at the surface of one of the layers making up the buttress material and, in embodiments, may be positioned at an exterior surface of the buttress material.


Some suitable non-limiting examples of reinforcement members include fabrics, meshes, monofilaments, multifilament braids, chopped fibers (sometimes referred to in the art as staple fibers) and combinations thereof. Where the reinforcement member is a mesh, it may be prepared using any technique known to those skilled in the art, such as knitting, weaving, tatting, knipling or the like. Where monofilaments or multifilament braids are used as the reinforcement member, the monofilaments or multifilament braids may be oriented in any desired manner. For example, the monofilaments or multifilament braids may be randomly positioned with respect to each other within the buttress material. As another example, the monofilaments or multifilament braids may be oriented in a common direction within the buttress material. Where chopped fibers are used as the reinforcement member, the chopped fibers may be oriented in any desired manner. For example, the chopped fibers may be randomly oriented or may be oriented in a common direction. The chopped fibers can thus form a non-woven material, such as a mat or a felt. The chopped fibers may be joined together (e.g., by heat fusing) or they may be unattached to each other. The chopped fibers may be of any suitable length. For example, the chopped may be from 0.1 mm to 100 mm in length, in embodiments, 0.4 mm to 50 mm in length. In an illustrative embodiment, the buttress material has randomly oriented chopped fibers that have not been previously fused together embedded within in the buttress material.


It is envisioned that the reinforcement member may be formed from any bioabsorbable, non-bioabsorbable, natural, or synthetic material previously described herein and combinations thereof. Where monofilaments or multifilament braids are used as the reinforcement member, any commercially available suture material may advantageously be employed as the reinforcement member.


In embodiments, at least one bioactive agent may be combined with the buttress material and/or any of the individual components (the porous layer, the non-porous layer and/or the reinforcement member) used to construct the buttress material. In these embodiments, the buttress material can also serve as a vehicle for delivery of the bioactive agent. The term “bioactive agent”, as used herein, is used in its broadest sense and includes any substance or mixture of substances that have clinical use. Consequently, bioactive agents may or may not have pharmacological activity per se, e.g., a dye, or fragrance. Alternatively a bioactive agent could be any agent which provides a therapeutic or prophylactic effect, a compound that affects or participates in tissue growth, cell growth, cell differentiation, an anti-adhesive compound, a compound that may be able to invoke a biological action such as an immune response, or could play any other role in one or more biological processes.


Examples of classes of bioactive agents which may be utilized in accordance with the present disclosure include anti-adhesives, antimicrobials, analgesics, antipyretics, anesthetics, antiepileptics, antihistamines, anti-inflammatories, cardiovascular drugs, diagnostic agents, sympathomimetics, cholinomimetics, antimuscarinics, antispasmodics, hormones, growth factors, muscle relaxants, adrenergic neuron blockers, antineoplastics, immunogenic agents, immunosuppressants, gastrointestinal drugs, diuretics, steroids, lipids, lipopolysaccharides, polysaccharides, and enzymes. It is also intended that combinations of bioactive agents may be used.


Anti-adhesive or anti-adhesion agents can be used to prevent adhesions from forming between the buttress material and the surrounding tissues opposite the target tissue. Some examples of these agents include, but are not limited to poly(vinyl pyrrolidone), carboxymethyl cellulose, hyaluronic acid, polyethylene oxide, poly vinyl alcohols and combinations thereof.


Suitable antimicrobial agents which may be included as a bioactive agent in the buttress material of the present disclosure include triclosan, also known as 2,4,4′-trichloro-2′-hydroxydiphenyl ether, chlorhexidine and its salts, including chlorhexidine acetate, chlorhexidine gluconate, chlorhexidine hydrochloride, and chlorhexidine sulfate, silver and its salts, including silver acetate, silver benzoate, silver carbonate, silver citrate, silver iodate, silver iodide, silver lactate, silver laurate, silver nitrate, silver oxide, silver palmitate, silver protein, and silver sulfadiazine, polymyxin, tetracycline, aminoglycosides, such as tobramycin and gentamicin, rifampicin, bacitracin, neomycin, chloramphenicol, miconazole, quinolones such as oxolinic acid, norfloxacin, nalidixic acid, pefloxacin, enoxacin and ciprofloxacin, penicillins such as oxacillin and pipracil, nonoxynol 9, fusidic acid, cephalosporins, and combinations thereof. In addition, antimicrobial proteins and peptides such as bovine lactoferrin and lactoferricin B may be included as a bioactive agent in the bioactive coating of the present disclosure.


Other bioactive agents which may be included as a bioactive agent in the buttress material in accordance with the present disclosure include: local anesthetics; non-steroidal antifertility agents; parasympathomimetic agents; psychotherapeutic agents; tranquilizers; decongestants; sedative hypnotics; steroids; sulfonamides; sympathomimetic agents; vaccines; vitamins; antimalarials; anti-migraine agents; anti-parkinson agents such as L-dopa; antispasmodics; anticholinergic agents (e.g. oxybutynin); antitussives; bronchodilators; cardiovascular agents such as coronary vasodilators and nitroglycerin; alkaloids; analgesics; narcotics such as codeine, dihydrocodeinone, meperidine, morphine and the like; non-narcotics such as salicylates, aspirin, acetaminophen, d-propoxyphene and the like; opioid receptor antagonists, such as naltrexone and naloxone; anti-cancer agents; anti-convulsants; anti-emetics; antihistamines; anti-inflammatory agents such as hormonal agents, hydrocortisone, prednisolone, prednisone, non-hormonal agents, allopurinol, indomethacin, phenylbutazone and the like; prostaglandins and cytotoxic drugs; estrogens; antibacterials; antibiotics; anti-fungals; anti-virals; anticoagulants; anticonvulsants; antidepressants; antihistamines; and immunological agents.


Other examples of suitable bioactive agents which may be included in the coating composition include viruses and cells, peptides, polypeptides and proteins, analogs, muteins, and active fragments thereof, such as immunoglobulins, antibodies, cytokines (e.g. lymphokines, monokines, chemokines), blood clotting factors, hemopoietic factors, interleukins (IL-2, IL-3, IL-4, IL-6), interferons (β-IFN, (α-IFN and γ-IFN), erythropoietin, nucleases, tumor necrosis factor, colony stimulating factors (e.g., GCSF, GM-CSF, MCSF), insulin, anti-tumor agents and tumor suppressors, blood proteins, gonadotropins (e.g., FSH, LH, CG, etc.), hormones and hormone analogs (e.g., growth hormone), vaccines (e.g., tumoral, bacterial and viral antigens); somatostatin; antigens; blood coagulation factors; growth factors (e.g., nerve growth factor, insulin-like growth factor); protein inhibitors, protein antagonists, and protein agonists; nucleic acids, such as antisense molecules, DNA and RNA; oligonucleotides; polynucleotides; and ribozymes.


Anvil buttress retention system 28 is provided to releasably secure anvil buttress material 24 to anvil 20 prior to stapling to tissue. Anvil buttress retention system 28 includes a distally raised region 46 formed on an undersurface 48 of anvil 20. As best shown in FIGS. 3 and 5, distally raised region 46 includes a pair of proximally extending fingers or projections 50 and 52 configured to releasably secure a distal end of anvil buttress material 24 on anvil 20. As used herein, the term “projections” refer to those structures provided on the jaws of the instrument which resemble fingers and are configured to engage buttress material positioned between the fingers in friction fit fashion. Projections 50 and 52 include respective necks 54, 56 and bulbous portions 58, 60 extending proximally from necks 54 and 56. Cut outs 62 and 64 are provided in a distal end 66 of anvil 20 for engagement with projections 50 and 52 of anvil 20. Cut outs 62 and 64 are configured with respective necks 68, 70 and bulbous portions 72 and 74 corresponding to necks 54, 56 and bulbous portions 58, 60 of anvil 20. Projections 50 and 52 along with cutouts 62 and 64 form pairs of interlocking fingers to hold anvil buttress material 24 on anvil 20.


Anvil buttress system 28 further includes a post 76 formed at a proximal end 78 of anvil 20. Anvil buttress material 24 is provided with a hole 80 at a proximal end 82 which is configured to engage post 76 and maintain anvil buttress material 24 taut across undersurface 48 of anvil 20.


As best shown in FIG. 3-6, post 76 is split into post halves 76a and 76b defining a channel 84 therebetween. Channel 84 corresponds to slot 38 in anvil 20 and allows for movement of driver 36, as well as the knife associated with driver 36, through slot 38 to close anvil 20 and cut anvil buttress material 24 in half after stapling.


Referring back for the moment to FIGS. 3 and 4, in order to assemble anvil buttress material 24 to anvil 20 using anvil buttress retention system 28, cut outs 62 and 64 at distal end 66 of anvil buttress material 24 are positioned over projections 50 and 52 on distally raised region 46 of anvil 20. Thereafter, anvil buttress material 24 is drawn taut proximally and hole 80 is positioned over post 76 at proximal end 78 of anvil 20 to secure anvil buttress material 24 against undersurface 48 of anvil 20.


Referring to FIGS. 7 and 8, there is disclosed an alternative embodiment of a retention system 86 for securing proximal end 82 of anvil buttress material 24 to anvil 20 in a manner to allow passage of driver 36 through slot 38 in anvil 20. Retention system 86 includes a mushroom shaped post or protrusion 88 having an enlarged cap 90 for placement through hole 80 in anvil buttress material 24. Cap 90 defines an underside surface or flange 92 configured to engage anvil buttress material 24. Similar to post 76 described hereinabove, protrusion 88 is split into protrusion halves 88a and 88b defining a slot 94 therebetween for passage of driver 36 and an associated knife blade. Cap 90 assists in preventing premature release of proximal end 82 of anvil buttress material 24. While not specifically shown, the area around hole 80 may include a perforated area to facilitate separation of anvil buttress material 24 from protrusion 88.


Referring to FIGS. 9 and 10, there is illustrated a further alternative embodiment of a retention system 94 for retaining proximal end 82 of anvil buttress material 24 on anvil 20. Anvil 20 is provided with a pair of horizontally spaced apart posts 96 and 98 positioned on either side of slot 38. Proximal end 82 of anvil buttress material 24 is provided with a pair of corresponding holes 100 and 102 configured to be engaged by posts 96 and 98, respectively. Posts 96 and 98 locate the area securing anvil buttress material 24 outwardly of slot 38 in anvil 20. This assists in maintaining outer edges 104 and 106 of anvil buttress material 24 taut during use of surgical stapler 10.


Referring now to FIGS. 11 and 12, cartridge buttress retention system 30 will now be described. As noted hereinabove, cartridge buttress retention system 30 is provided to retain cartridge buttress material 26 on staple cartridge 22 prior to stapling of tissue. Staple cartridge 22 generally includes a U-shaped outer channel 108 surrounding a staple containing insert 110. Staple containing insert 110 is provided with rows of staple pockets 112, the function of which is described in more detail hereinbelow. A knife channel 114 passes longitudinally through staple containing insert 110 between rows of staple pockets 12.


Referring for the moment to FIGS. 11 and 15, cartridge buttress retention system 30 includes a post 116 formed at a distal end 118 of staple containing insert 110. Post 116 is similar to post 76 described hereinabove and is split into halves 116a and 116b to accommodate the passage of a knife blade to sever tissue and cartridge buttress material 26. Cartridge buttress material 26 includes a corresponding hole 20 formed in a distal end 122 of cartridge buttress material and configured to fit over post 116 on staple containing insert 110.


Referring back to FIGS. 11 and 12, and with regard to FIG. 13, cartridge buttress retention system 30 further includes a pair of distally extending and relatively straight, spaced apart fingers or projections 124 and 126 formed in a proximal end 128 of staple containing insert 110. Projections 124 and 126 are positioned on either side of knife channel 114 to secure cartridge buttress material 26 adjacent outer edges 130 and 132 of cartridge buttress material 26. Cartridge buttress material 26 is provided with corresponding slots 134 and 136 formed in a proximal end 138 of cartridge buttress material 26. Slots 134 and 136 are configured to engage projections 124 and 126 of staple containing insert 110 in friction fit fashion to retain proximal end 138 of cartridge buttress material 26 on proximal end 128 of staple containing insert 110.


In order to assemble cartridge buttress retention system 30, hole 120 in cartridge buttress material 26 is positioned over protrusion 116 on distal end 118 of staple containing insert 110. Thereafter, proximal end 138 of cartridge buttress material 26 is positioned over proximal end 128 of staple containing insert 110. Slots 134 and 136 in anvil buttress material 26 are forced over projections 124 and 126 on staple containing insert 110 to engage anvil buttress material 26 with staple containing inset 110 in friction fit fashion.


Referring for the moment to FIG. 14, in an alternative embodiment, proximal end 128 of staple containing insert 110 is provided with multiple sets of fingers or projections 140, 142 and 144, 146 positioned on either side of knife channel 114. Projections 140, 142 and 144, 146 engage corresponding sets of slots 148, 150 and 152, 154, respectively, to secure proximal end 138 of cartridge buttress material 26 to proximal end 128 of staple containing insert 110. By providing multiple sets of fingers on the jaw and corresponding slots in the buttress material, the surface area available for frictional contact is increased providing a more secure connection. While not specifically shown, more than two sets of fingers and slots may be provided depending on the nature of the buttress material and amount of frictional contact required.


Referring now to FIGS. 16-21, and initially with regard to FIGS. 16 and 17, alternative methods of releasably securing buttress material to a jaw of a surgical instrument will now be described. A split protrusion 156, similar to protrusion 88 described hereinabove, is formed on a distal end 118 of staple containing insert 110 and includes cap halves 158a and 158b defining flanges 160a and 160b. Hole 120 in distal end 122 of cartridge buttress material 26 fits over split protrusion 156 to secure distal end 122 of cartridge buttress material 26 to distal end 118 of staple containing insert 110.


Referring to FIGS. 18 and 19, distal ends 118 and 120 of staple containing insert 110 and cartridge buttress material 26 may be provided with spaced apart posts 162,164 and spaced apart holes 166, 168, respectively. Posts 162, 164 and holes 166, 168 function substantially identically to posts 96, 98 and holes 100, 102, described hereinabove, to secure distal end 122 of cartridge buttress material 26 to distal end 118 of staple containing insert 110.


With respect to FIGS. 20 and 21, a solid, unsplit post 170 is provided on distal end 118 of staple containing insert 110. Post 170 is located distally of a distal end 172 of knife channel 114. A hole 174 is provided in distal end 120 of cartridge buttress material 26 and a longitudinal slit 176 is formed through the area defining hole 174. In use, a knife associated with surgical stapler 10 cuts through cartridge buttress material 26 through the length of knife channel 114. After cartridge buttress material 26 has been stapled to tissue and almost completely been cut in half, longitudinal slit 176 allows cartridge buttress material 26 to separate in half without tearing or snagging.


Referring now to FIGS. 22 through 26, and initially with respect to FIGS. 22 and 23, the use of surgical stapler 10 to staple and divide a tubular tissue section T will now be described. Initially, jaw assembly 16, including anvil 20 and staple containing cartridge 22 are positioned around the tissue T to be stapled. Driver 36 is in a proximal position relative to anvil slot 38. As best shown in FIG. 23, staple containing insert 110 includes staples 178 positioned within individual staple pockets 180 of row of staple pockets 112. Staples 178 are of a conventional type and include a backspan 182 having a pair of legs 184 and 186 extending from backspan 182. Legs 184 and 186 terminate in tissue penetrating tips 188 and 190. Pushers 192 are located within staple pockets 180 and are positioned between staples 178 and the path of a drive bar 194.


Referring now to FIG. 24, surgical stapler 10 is initially actuated by movement of trigger 32 relative to handle 12 (FIG. 1) causing driver 36 to move in the direction of arrow B and against sloped edge 40 of anvil 20 thereby causing anvil 20 to be moved to the closed position relative to staple cartridge 22. As drive bar 194 advances distally within staple containing insert 110, drive bar 194 urges pushers 192 upwardly against backspans 182 of staples 178 driving staples 178 through cartridge buttress material 26, tissue T, anvil buttress material 24 and towards staple clinching pockets 44 in anvil 20. Tissue penetrating tips 188 and 190 are bent within staple clinching pockets 44 in anvil 20 to thereby secure anvil buttress material 24 against tissue T while backspan 182 secures cartridge buttress material 26 against tissue T.


While not specifically shown, upon full actuation of surgical stapler 10, a knife blade associated with surgical stapler 10 and carried by driver 36 cuts tissue T, as well as anvil buttress material 24 and cartridge buttress material 26 between the rows of now clinched staples 102. Upon movement of anvil 20 to the open position spaced apart from staple cartridge 22, anvil buttress material 24 pulls away from anvil 20 and cartridge buttress material 26 pulls away from staple cartridge 22. Specifically, distal end 122 of cartridge buttress material 26 is cut through by the knife and is released from post 116. Proximal end 138 of cartridge buttress material 26 pulls free from longitudinal projections 124, 126 at proximal end 128 of staple containing insert 110. Likewise, distal end 66 of anvil buttress material 24 pulls free from proximally extending projections 50, 52 and proximal end 82 of anvil buttress material 24 pulls free from post 78.


The resulting tissue T, divided and stapled closed with staples 178, is best illustrated in FIGS. 25 and 26. Specifically, cartridge buttress material 26 is secured against tissue T by backspans 182 of staples 178 and anvil buttress material 24 is secured against tissue T by the now clinched tissue penetrating tips 188 and 190 of staples 178. In this manner, anvil buttress material 24 and cartridge buttress material 26 are stapled to tissue T thereby sealing and reinforcing these staple lines created by staples 178.


It will be understood that various modifications may be made to the embodiments disclosed herein. For example, various numbers of interlocking fingers or projections may be provided to increase the frictional contact between a jaw and an associated buttress material. Further, the disclosed buttress materials may be provided with various perforated regions to facilitate release from the disclosed fingers or projections and posts. Therefore, the above description should not be construed as limiting, but merely as exemplifications of particular embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.

Claims
  • 1. A surgical stapler comprising: a jaw assembly including a staple cartridge and an anvil, at least one of the staple cartridge or anvil having: a tissue facing surface defining at least one fixed projection extending out from the tissue facing surface of the at least one of the staple cartridge or anvil;at least one raised region defining a raised region surface; anda buttress material having at least one opening shaped for receiving the at least one fixed projection so that the buttress material is releasably disposed such that the buttress material is flush with the raised region surface of the at least one raised region, the buttress material having a bioactive agent for delivery of the bioactive agent to tissue, wherein the bioactive agent is an anti-tumor agent or a tumor suppressor, and the at least one opening being positioned over the at least one fixed projection.
  • 2. The surgical stapler according to claim 1, wherein the at least one of the staple cartridge or anvil includes a longitudinally extending knife slot, the at least one projection being separated by the knife slot into a first portion and a second portion.
  • 3. The surgical stapler as recited in claim 1, wherein the at least one projection is disposed near a distal end of the at least one of the staple cartridge or anvil.
  • 4. The surgical stapler as recited in claim 3, further comprising at least one other projection disposed near a proximal end of the at least one of the staple cartridge or anvil.
  • 5. The surgical stapler as recited in claim 1, wherein the at least one projection includes a neck portion and a bulbous portion.
  • 6. The surgical stapler as recited in claim 1, wherein the buttress material comprises a bioabsorbable material.
  • 7. The surgical stapler as recited in claim 1, wherein the buttress material comprises a natural biological polymer.
  • 8. The surgical stapler as recited in claim 1, wherein the bioactive agent includes a further bioactive agent selected from the group consisting of anti-adhesives, antimicrobials, analgesics, antipyretics, anesthetics, antiepileptics, antihistimines, anti-inflammatories, cardiovascular drugs, diagnostic agents, sympathomimetics, cholinomimetics, antimuscarinics, antispasmodics, hormones, growth factors, muscle relaxants, adrenergic neuron blockers, antineoplastics, immunogenic agents, immunosuppressants, gastrointestinal drugs, diuretics, steroids, lipids, lipopolysaccharides, polysaccharides, and enzymes.
  • 9. The surgical stapler as recited in claim 1, wherein the staple cartridge defines at least one linear row of staple pockets.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 13/652,502 filed Oct. 16, 2012, now U.S. Pat. No. 8,616,430, which is a continuation of U.S. patent application Ser. No. 13/307,581 filed Nov. 30, 2011, now U.S. Pat. No. 8,308,046, which is a continuation of U.S. patent application Ser. No. 13/051,475 filed Mar. 18, 2011, now U.S. Pat. No. 8,083,119, which is a continuation of U.S. patent application Ser. No. 12/687,400 filed Jan. 14, 2010, now U.S. Pat. No. 7,909,224, which is a continuation of U.S. patent application Ser. No. 11/820,239 filed Jun. 18, 2007, now U.S. Pat. No. 7,665,646, and the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.

US Referenced Citations (367)
Number Name Date Kind
3054406 Usher Sep 1962 A
3079606 Bobrov et al. Mar 1963 A
3124136 Usher Mar 1964 A
3490675 Green et al. Jan 1970 A
3499591 Green Mar 1970 A
4347847 Usher Sep 1982 A
4354628 Green Oct 1982 A
4429695 Green Feb 1984 A
4452245 Usher Jun 1984 A
4605730 Shalaby et al. Aug 1986 A
4655221 Devereux Apr 1987 A
4834090 Moore May 1989 A
4838884 Dumican et al. Jun 1989 A
4927640 Dahlinder et al. May 1990 A
4930674 Barak Jun 1990 A
5002551 Linsky et al. Mar 1991 A
5014899 Presty et al. May 1991 A
5040715 Green et al. Aug 1991 A
5065929 Schulze et al. Nov 1991 A
5205459 Brinkerhoff et al. Apr 1993 A
5263629 Trumbull et al. Nov 1993 A
5307976 Olson et al. May 1994 A
5312023 Green et al. May 1994 A
5314471 Brauker et al. May 1994 A
5318221 Green et al. Jun 1994 A
5326013 Green et al. Jul 1994 A
5332142 Robinson et al. Jul 1994 A
5344454 Clarke et al. Sep 1994 A
5392979 Green et al. Feb 1995 A
5397324 Carroll et al. Mar 1995 A
5425745 Green et al. Jun 1995 A
5441193 Gravener Aug 1995 A
5441507 Wilk Aug 1995 A
5443198 Viola et al. Aug 1995 A
5468253 Bezwada et al. Nov 1995 A
5503638 Cooper et al. Apr 1996 A
5542594 McKean et al. Aug 1996 A
5549628 Cooper et al. Aug 1996 A
5575803 Cooper et al. Nov 1996 A
5653756 Clarke et al. Aug 1997 A
5683809 Freeman et al. Nov 1997 A
5690675 Sawyer et al. Nov 1997 A
5702409 Rayburn et al. Dec 1997 A
5752965 Francis et al. May 1998 A
5762256 Mastri et al. Jun 1998 A
5766188 Igaki Jun 1998 A
5769892 Kingwell Jun 1998 A
5782396 Mastri et al. Jul 1998 A
5799857 Robertson et al. Sep 1998 A
5810855 Rayburn et al. Sep 1998 A
5814057 Oi et al. Sep 1998 A
5833695 Yoon Nov 1998 A
5843096 Igaki et al. Dec 1998 A
5895412 Tucker Apr 1999 A
5895415 Chow et al. Apr 1999 A
5902312 Frater et al. May 1999 A
5908427 McKean et al. Jun 1999 A
5915616 Viola et al. Jun 1999 A
5931847 Bittner et al. Aug 1999 A
5964774 McKean et al. Oct 1999 A
5997895 Narotam et al. Dec 1999 A
6019791 Wood Feb 2000 A
6030392 Dakov et al. Feb 2000 A
6032849 Mastri et al. Mar 2000 A
6045560 McKean et al. Apr 2000 A
6063097 Oi et al. May 2000 A
6080169 Turtel Jun 2000 A
6099551 Gabbay Aug 2000 A
6149667 Hovland et al. Nov 2000 A
6155265 Hammerslag Dec 2000 A
6210439 Firmin et al. Apr 2001 B1
6214020 Mulhauser et al. Apr 2001 B1
6241139 Milliman et al. Jun 2001 B1
6258107 Balazs et al. Jul 2001 B1
6267772 Mulhauser et al. Jul 2001 B1
6273897 Dalessandro et al. Aug 2001 B1
6280453 Kugel et al. Aug 2001 B1
6299631 Shalaby Oct 2001 B1
6312457 DiMatteo et al. Nov 2001 B1
6312474 Francis et al. Nov 2001 B1
6325810 Hamilton et al. Dec 2001 B1
6436030 Rehil Aug 2002 B2
6454780 Wallace Sep 2002 B1
6461368 Fogarty et al. Oct 2002 B2
6503257 Grant et al. Jan 2003 B2
6514283 DiMatteo et al. Feb 2003 B2
6517566 Hovland et al. Feb 2003 B1
6551356 Rousseau Apr 2003 B2
6592597 Grant et al. Jul 2003 B2
6638285 Gabbay Oct 2003 B2
6652594 Francis et al. Nov 2003 B2
6656193 Grant Dec 2003 B2
6669735 Pelissier Dec 2003 B1
6677258 Carroll et al. Jan 2004 B2
6685714 Rousseau Feb 2004 B2
6702828 Whayne Mar 2004 B2
6704210 Myers Mar 2004 B1
6723114 Shalaby Apr 2004 B2
6726706 Dominguez Apr 2004 B2
6736823 Darois et al. May 2004 B2
6736854 Vadurro et al. May 2004 B2
6746458 Cloud Jun 2004 B1
6773458 Brauker et al. Aug 2004 B1
6896684 Monassevitch et al. May 2005 B2
6927315 Heinecke et al. Aug 2005 B1
6939358 Palacios et al. Sep 2005 B2
6946196 Foss Sep 2005 B2
6959851 Heinrich Nov 2005 B2
7087065 Ulmsten et al. Aug 2006 B2
7108701 Evens et al. Sep 2006 B2
7128748 Mooradian et al. Oct 2006 B2
7141055 Abrams et al. Nov 2006 B2
7147138 Shelton, IV Dec 2006 B2
7160299 Baily Jan 2007 B2
7232449 Sharkawy et al. Jun 2007 B2
7241300 Sharkawy et al. Jul 2007 B2
7307031 Carroll et al. Dec 2007 B2
7311720 Mueller et al. Dec 2007 B2
7377928 Zubik et al. May 2008 B2
7434717 Shelton, IV et al. Oct 2008 B2
7438209 Hess et al. Oct 2008 B1
7547312 Bauman et al. Jun 2009 B2
7559937 de la Torre et al. Jul 2009 B2
7594921 Browning Sep 2009 B2
7604151 Hess et al. Oct 2009 B2
7665646 Prommersberger Feb 2010 B2
7666198 Suyker et al. Feb 2010 B2
7669747 Weisenburgh, II et al. Mar 2010 B2
7717313 Bettuchi et al. May 2010 B2
7722642 Williamson, IV May 2010 B2
7744627 Orban, III et al. Jun 2010 B2
7776060 Mooradian Aug 2010 B2
7793813 Bettuchi Sep 2010 B2
7799026 Schechter et al. Sep 2010 B2
7823592 Bettuchi et al. Nov 2010 B2
7824420 Eldridge et al. Nov 2010 B2
7845533 Marczyk et al. Dec 2010 B2
7845536 Viola et al. Dec 2010 B2
7846149 Jankowski Dec 2010 B2
7892247 Conston et al. Feb 2011 B2
7909224 Prommersberger Mar 2011 B2
7909837 Crows et al. Mar 2011 B2
7938307 Bettuchi May 2011 B2
7942890 D'Agostino et al. May 2011 B2
7950561 Aranyi May 2011 B2
7951166 Orban May 2011 B2
7967179 Olson Jun 2011 B2
7988027 Olson Aug 2011 B2
8011550 Aranyi Sep 2011 B2
8016177 Bettuchi Sep 2011 B2
8016178 Olson Sep 2011 B2
8028883 Stopek Oct 2011 B2
8062330 Prommersberger Nov 2011 B2
8083119 Prommersberger Dec 2011 B2
8123766 Bauman Feb 2012 B2
8123767 Bauman Feb 2012 B2
8146791 Bettuchi Apr 2012 B2
8157149 Olson Apr 2012 B2
8157151 Ingmanson Apr 2012 B2
8167895 D'Agostino May 2012 B2
8192460 Orban Jun 2012 B2
8210414 Bettuchi Jul 2012 B2
8225799 Bettuchi Jul 2012 B2
8225981 Criscuolo et al. Jul 2012 B2
8231043 Tarinelli Jul 2012 B2
8235273 Olson Aug 2012 B2
8245901 Stopek Aug 2012 B2
8256654 Bettuchi Sep 2012 B2
8257391 Orban Sep 2012 B2
8276800 Bettuchi Oct 2012 B2
8286849 Bettuchi Oct 2012 B2
8308042 Aranyi Nov 2012 B2
8308045 Bettuchi Nov 2012 B2
8308046 Prommersberger Nov 2012 B2
8312885 Bettuchi Nov 2012 B2
8313014 Bettuchi Nov 2012 B2
8348126 Olson Jan 2013 B2
8348130 Shah Jan 2013 B2
8365972 Aranyi et al. Feb 2013 B2
8371491 Huitema Feb 2013 B2
8371492 Aranyi Feb 2013 B2
8371493 Aranyi Feb 2013 B2
8393514 Shelton, IV Mar 2013 B2
8408440 Olson Apr 2013 B2
8413871 Racenet Apr 2013 B2
8424742 Bettuchi Apr 2013 B2
8453652 Stopek Jun 2013 B2
8453904 Eskaros Jun 2013 B2
8453909 Olson Jun 2013 B2
8453910 Bettuchi Jun 2013 B2
8464925 Hull et al. Jun 2013 B2
8474677 Woodard, Jr. Jul 2013 B2
8479968 Hodgkinson Jul 2013 B2
8485414 Criscuolo et al. Jul 2013 B2
8496683 Prommersberger Jul 2013 B2
8511533 Viola Aug 2013 B2
8512402 Marczyk Aug 2013 B2
8529600 Woodard, Jr. Sep 2013 B2
8540131 Swayze Sep 2013 B2
8551138 Orban Oct 2013 B2
8556918 Bauman Oct 2013 B2
8561873 Ingmanson Oct 2013 B2
8584920 Hodgkinson Nov 2013 B2
8590762 Hess Nov 2013 B2
8616430 (Prommersberger) Stopek Dec 2013 B2
8631989 Aranyi Jan 2014 B2
8668129 Olson Mar 2014 B2
8684250 Bettuchi Apr 2014 B2
8757466 Olson Jun 2014 B2
8789737 Hodgkinson Jul 2014 B2
8820606 Hodgkinson Sep 2014 B2
20020028243 Masters Mar 2002 A1
20020091397 Chen Jul 2002 A1
20030065345 Weadock Apr 2003 A1
20030083676 Wallace May 2003 A1
20030120284 Palacios Jun 2003 A1
20030181927 Wallace Sep 2003 A1
20030183671 Mooradian et al. Oct 2003 A1
20030208231 Williamson, IV et al. Nov 2003 A1
20040107006 Francis et al. Jun 2004 A1
20040254590 Hoffman et al. Dec 2004 A1
20040260315 Dell et al. Dec 2004 A1
20050002981 Lahtinen et al. Jan 2005 A1
20050021085 Abrams et al. Jan 2005 A1
20050059996 Bauman et al. Mar 2005 A1
20050059997 Bauman et al. Mar 2005 A1
20050070929 Dalessandro et al. Mar 2005 A1
20050118435 DeLucia et al. Jun 2005 A1
20050143756 Jankowski Jun 2005 A1
20050149073 Arani et al. Jul 2005 A1
20060004407 Hiles et al. Jan 2006 A1
20060135992 Bettuchi Jun 2006 A1
20060173470 Oray et al. Aug 2006 A1
20060178683 Shimoji et al. Aug 2006 A1
20060271104 Viola et al. Nov 2006 A1
20070026031 Bauman et al. Feb 2007 A1
20070034669 de la Torre et al. Feb 2007 A1
20070049953 Shimoji et al. Mar 2007 A2
20070123839 Rousseau et al. May 2007 A1
20070179528 Soltz et al. Aug 2007 A1
20070203509 Bettuchi Aug 2007 A1
20070203510 Bettuchi Aug 2007 A1
20070246505 Pace-Floridia et al. Oct 2007 A1
20080029570 Shelton et al. Feb 2008 A1
20080082126 Murray et al. Apr 2008 A1
20080110959 Orban et al. May 2008 A1
20080125812 Zubik et al. May 2008 A1
20080140115 Stopek Jun 2008 A1
20080161831 Bauman et al. Jul 2008 A1
20080161832 Bauman et al. Jul 2008 A1
20080169327 Shelton et al. Jul 2008 A1
20080169328 Shelton Jul 2008 A1
20080169329 Shelton et al. Jul 2008 A1
20080169330 Shelton et al. Jul 2008 A1
20080169331 Shelton et al. Jul 2008 A1
20080169332 Shelton et al. Jul 2008 A1
20080169333 Shelton et al. Jul 2008 A1
20080200949 Hiles Aug 2008 A1
20080290134 Bettuchi et al. Nov 2008 A1
20080308608 Prommersberger Dec 2008 A1
20080314960 Marczyk et al. Dec 2008 A1
20090001121 Hess et al. Jan 2009 A1
20090001122 Prommersberger et al. Jan 2009 A1
20090001123 Morgan et al. Jan 2009 A1
20090001124 Hess et al. Jan 2009 A1
20090001125 Hess et al. Jan 2009 A1
20090001126 Hess et al. Jan 2009 A1
20090001128 Weisenburgh, II et al. Jan 2009 A1
20090001130 Hess et al. Jan 2009 A1
20090005808 Hess et al. Jan 2009 A1
20090030452 Bauman et al. Jan 2009 A1
20090043334 Bauman et al. Feb 2009 A1
20090076510 Bell et al. Mar 2009 A1
20090076528 Sgro Mar 2009 A1
20090078739 Viola Mar 2009 A1
20090095791 Eskaros et al. Apr 2009 A1
20090095792 Bettuchi Apr 2009 A1
20090120994 Murray et al. May 2009 A1
20090134200 Tarinelli et al. May 2009 A1
20090206125 Huitema et al. Aug 2009 A1
20090206126 Huitema et al. Aug 2009 A1
20090206139 Hall et al. Aug 2009 A1
20090206141 Huitema et al. Aug 2009 A1
20090206142 Huitema et al. Aug 2009 A1
20090206143 Huitema et al. Aug 2009 A1
20090218384 Aranyi Sep 2009 A1
20090277947 Viola Nov 2009 A1
20090287230 D'Agostino et al. Nov 2009 A1
20100012704 Tarinelli Racenet et al. Jan 2010 A1
20100065606 Stopek Mar 2010 A1
20100065607 Orban, III et al. Mar 2010 A1
20100072254 Aranyi et al. Mar 2010 A1
20100147921 Olson Jun 2010 A1
20100147922 Olson Jun 2010 A1
20100147923 D'Agostino et al. Jun 2010 A1
20100243707 Olson et al. Sep 2010 A1
20100243708 Aranyi et al. Sep 2010 A1
20100243711 Olson et al. Sep 2010 A1
20100249805 Olson et al. Sep 2010 A1
20100264195 Bettuchi Oct 2010 A1
20100282815 Bettuchi et al. Nov 2010 A1
20110024476 Bettuchi et al. Feb 2011 A1
20110024481 Bettuchi et al. Feb 2011 A1
20110036894 Bettuchi Feb 2011 A1
20110042442 Viola et al. Feb 2011 A1
20110046650 Bettuchi Feb 2011 A1
20110057016 Bettuchi Mar 2011 A1
20110087279 Shah et al. Apr 2011 A1
20110215132 Aranyi Sep 2011 A1
20120074199 Olson Mar 2012 A1
20120080336 Shelton Apr 2012 A1
20120187179 Gleiman Jul 2012 A1
20120241499 Baxter Sep 2012 A1
20120273547 Hodgkinson et al. Nov 2012 A1
20130037596 Bear et al. Feb 2013 A1
20130105548 Hodgkinson May 2013 A1
20130105553 Racenet May 2013 A1
20130112732 Aranyi May 2013 A1
20130112733 Aranyi May 2013 A1
20130146641 Shelton Jun 2013 A1
20130153633 Casasanta Jun 2013 A1
20130153634 Carter Jun 2013 A1
20130153635 Hodgkinson Jun 2013 A1
20130153636 Shelton Jun 2013 A1
20130153638 Carter Jun 2013 A1
20130153639 Hodgkinson Jun 2013 A1
20130153640 Hodgkinson Jun 2013 A1
20130153641 Shelton Jun 2013 A1
20130161374 Swayze Jun 2013 A1
20130181031 Olson Jul 2013 A1
20130193186 Racenet Aug 2013 A1
20130193190 Carter Aug 2013 A1
20130193191 Stevenson Aug 2013 A1
20130193192 Casasanta Aug 2013 A1
20130209659 Racenet Aug 2013 A1
20130221062 Hodgkinson Aug 2013 A1
20130240600 Bettuchi Sep 2013 A1
20130240601 Bettuchi Sep 2013 A1
20130240602 Stopek Sep 2013 A1
20130277411 Hodgkinson Oct 2013 A1
20130306707 Viola Nov 2013 A1
20130310873 Prommersberger Nov 2013 A1
20130327807 Olson Dec 2013 A1
20140012317 Orban Jan 2014 A1
20140021242 Hodgkinson Jan 2014 A1
20140027490 Marczyk Jan 2014 A1
20140034704 Ingmanson Feb 2014 A1
20140048580 Merchant Feb 2014 A1
20140061280 Ingmanson Mar 2014 A1
20140061281 Hodgkinson Mar 2014 A1
20140084042 Stopek Mar 2014 A1
20140097224 Prior Apr 2014 A1
20140117066 Aranyi May 2014 A1
20140130330 Olson May 2014 A1
20140131418 Kostrzewski May 2014 A1
20140131419 Bettuchi May 2014 A1
20140138423 Whitfield May 2014 A1
20140151431 Hodgkinson Jun 2014 A1
20140155916 Hodgkinson Jun 2014 A1
20140158742 Stopek Jun 2014 A1
20140166721 Stevenson Jun 2014 A1
20140197224 Penna Jul 2014 A1
20140203061 Hodgkinson Jul 2014 A1
20140217147 Milliman Aug 2014 A1
20140217148 Penna Aug 2014 A1
20140239046 Milliman Aug 2014 A1
20140239047 Hodgkinson Aug 2014 A1
Foreign Referenced Citations (59)
Number Date Country
2 667 434 May 2008 CA
1 99 24 311 Nov 2000 DE
0 594 148 Apr 1994 EP
0 327 022 Apr 1995 EP
0 667 119 Aug 1995 EP
1 064 883 Jan 2001 EP
1 256 317 Nov 2002 EP
1 256 318 Nov 2002 EP
1 520 525 Apr 2005 EP
1 621 141 Feb 2006 EP
1 702 570 Sep 2006 EP
1 759 640 Mar 2007 EP
1 815 804 Aug 2007 EP
1 825 820 Aug 2007 EP
1 929 958 Jun 2008 EP
1 994 890 Nov 2008 EP
2 005 894 Dec 2008 EP
2 005 895 Dec 2008 EP
2 008 595 Dec 2008 EP
2 090 231 Aug 2009 EP
2 090 244 Aug 2009 EP
2 090 252 Aug 2009 EP
2 198 787 Jun 2010 EP
2 236 098 Oct 2010 EP
2 236 099 Oct 2010 EP
2 311 386 Apr 2011 EP
2 436 348 Apr 2012 EP
2 462 880 Jun 2012 EP
2 517 637 Oct 2012 EP
2 586 380 May 2013 EP
2 604 195 Jun 2013 EP
2 604 197 Jun 2013 EP
2 620 106 Jul 2013 EP
2 630 922 Aug 2013 EP
2 644 125 Oct 2013 EP
2000-166933 Jun 2000 JP
2002-202213 Jul 2002 JP
2007-124166 May 2007 JP
WO 9005489 May 1990 WO
WO 9516221 Jun 1995 WO
WO 9622055 Jul 1996 WO
WO 9701989 Jan 1997 WO
WO 9713463 Apr 1997 WO
WO 9817180 Apr 1998 WO
WO 9945849 Sep 1999 WO
WO 03082126 Oct 2003 WO
WO 03088845 Oct 2003 WO
WO 03094743 Nov 2003 WO
WO 03105698 Dec 2003 WO
WO 2005079675 Sep 2005 WO
WO 2006023578 Mar 2006 WO
WO 2006044490 Apr 2006 WO
WO 2006083748 Aug 2006 WO
WO 2007121579 Nov 2007 WO
WO 2008057281 May 2008 WO
WO 2008109125 Sep 2008 WO
WO 2010075298 Jul 2010 WO
WO 2011143183 Nov 2011 WO
WO 2012044848 Apr 2012 WO
Non-Patent Literature Citations (55)
Entry
European Search Report corresponding to EP 05 02 2585.3, completed Jan. 25, 2006 and mailed Feb. 3, 2006; 4 pages.
European Search Report corresponding to EP 06 00 4598, completed Jun. 22, 2006; 2 pages.
European Search Report corresponding to EP 06 01 6962.0, completed Jan. 3, 2007 and mailed Jan. 11, 2007; 10 pages.
International Search Report corresponding to International Application No. PCT/US2005/036740, completed Feb. 20, 2007 and mailed Mar. 23, 2007; 8 pages.
International Search Report corresponding to International Application No. PCT/US2007/022713, completed Apr. 21, 2008 and mailed May 15, 2008; 1 page.
International Search Report corresponding to International Application No. PCT/US2008/002981, completed Jun. 9, 2008 and mailed Jun. 26, 2008; 2 pages.
European Search Report corresponding to EP 08 25 1779, completed Jul. 14, 2008 and mailed Jul. 23, 2008; 5 pages.
European Search Report corresponding to EP 08 25 1989.3, completed Mar. 11, 2010 and mailed Mar. 24, 2010; 6 pages.
European Search Report corresponding to EP 10 25 0639.1, completed Jun. 17, 2010 and mailed Jun. 28, 2010; 7 pages.
European Search Report corresponding to EP 10 25 0715.9, completed Jun. 30, 2010 and mailed Jul. 20, 2010; 3 pages.
European Search Report corresponding to EP 05 80 4382.9, completed Oct. 5, 2010 and mailed Oct. 12, 2010; 3 pages.
European Search Report corresponding to EP 10 25 1437.9, completed Nov. 22, 2010 and mailed Dec. 16, 2010; 3 pages.
European Search Report corresponding to EP 09 25 2897.5, completed Feb. 7, 2011 and mailed Feb. 15, 2011; 3 pages.
European Search Report corresponding to EP 10 25 0642.5, completed Mar. 25, 2011 and mailed Apr. 4, 2011; 4 pages.
European Search Report corresponding to EP 11 18 8309.6, completed Dec. 15, 2011 and mailed Jan. 12, 2012; 3 pages.
European Search Report corresponding to EP 12 15 2229.6, completed Feb. 23, 2012 and mailed Mar. 1, 2012; 4 pages.
European Search Report corresponding to EP 12 15 0511.9, completed Apr. 16, 2012 and mailed Apr. 24, 2012; 7 pages.
European Search Report corresponding to EP 12 15 2541.4, completed Apr. 23, 2012 and mailed May 3, 2012; 10 pages.
European Search Report corresponding to EP 12 16 5609.4, completed Jul. 5, 2012 and mailed Jul. 13, 2012; 8 pages.
European Search Report corresponding to EP 12 15 8861.0, completed Jul. 17, 2012 and mailed Jul. 24, 2012; 9 pages.
European Search Report corresponding to EP 12 16 5878.5, completed Jul. 24, 2012 and mailed Aug. 6, 2012; 8 pages.
Extended European Search Report corresponding to EP 12 19 1035.0, completed Jan. 11, 2013 and mailed Jan. 18, 2013; 7 pages.
Extended European Search Report corresponding to EP 12 18 6175.1, completed Jan. 15, 2013 and mailed Jan. 23, 2013; 7 pages.
Extended European Search Report corresponding to EP 12 19 1114.3, completed Jan. 23, 2013 and mailed Jan. 31, 2013; 10 pages.
Extended European Search Report corresponding to EP 12 19 2224.9, completed Mar. 14, 2013 and mailed Mar. 26, 2013; 8 pages.
Extended European Search Report corresponding to EP 12 19 6904.2, completed Mar. 28, 2013 and mailed Jul. 26, 2013; 8 pages.
Extended European Search Report corresponding to EP 12 19 6911.7, completed Apr. 18, 2013 and mailed Apr. 24, 2013; 8 pages.
Extended European Search Report corresponding to EP 07 00 5842.5, completed May 13, 2013 and mailed May 29, 2013; 7 pages.
Extended European Search Report corresponding to EP 12 19 8776.2, completed May 16, 2013 and mailed May 27, 2013; 8 pages.
Extended European Search Report corresponding to EP 12 19 8749.9, completed May 21, 2013 and mailed May 31, 2013; 8 pages.
Extended European Search Report corresponding to EP 13 15 6297.7, completed Jun. 4, 2013 and mailed Jun. 13, 20131; 7 pages.
Extended European Search Report corresponding to EP 13 17 3985.6, completed Aug. 19, 2013 and mailed Aug. 28, 2013; 6 pages.
Extended European Search Report corresponding to EP 13 17 3986.4, completed Aug. 20, 2013 and mailed Aug. 29, 2013; 7 pages.
Extended European Search Report corresponding to EP 13 17 7437.4, completed Sep. 11, 2013 and mailed Sep. 19, 2013; (6 pp).
Extended European Search Report corresponding to EP 13 17 7441.6, completed Sep. 11, 2013 and mailed Sep. 19, 2013; (6 pp).
Extended European Search Report corresponding to EP 07 86 1534.1, completed Sep. 20, 2013 and mailed Sep. 30, 2013; (5 pp).
Extended European Search Report corresponding to EP 13 18 3876.5, completed Oct. 14, 2013 and mailed Oct. 24, 2013; (5 pp).
Extended European Search Report corresponding to EP 13 17 1856.1, completed Oct. 29, 2013 and mailed Nov. 7, 2013; (8 pp).
Extended European Search Report corresponding to EP 13 18 0373.6, completed Oct. 31, 2013 and mailed Nov. 13, 2013; (7 pp).
Extended European Search Report corresponding to EP 13 18 0881.8, completed Nov. 5, 2013 and mailed Nov. 14, 2013; (6 pp).
Extended European Search Report corresponding to EP 13 17 6895.4, completed Nov. 29, 2013 and mailed Dec. 12, 2013; (5 pp).
Extended European Search Report corresponding to EP 13 18 2911.1, completed Dec. 2, 2013 and mailed Dec. 16, 2013; (8 pp).
Extended European Search Report corresponding to EP 10 25 1795.0, completed Dec. 11, 2013 and mailed Dec. 20, 2013; (6 pp).
Extended European Search Report corresponding to EP 13 18 7911.6, completed Jan. 22, 2014 and mailed Jan. 31, 2014; (8 pp).
Extended European Search Report corresponding to EP 08 72 6500,5, completed Feb. 20, 2014 and mailed Mar. 3, 2014; (7 pp).
Extended European Search Report corresponding to EP 13 19 5919.9, completed Feb. 10, 2014 and mailed Mar. 3, 2014; (7 pp).
Extended European Search Report corresponding to EP 13 19 2123.1, completed Jan. 30, 2014 and mailed Feb. 10, 2014; (8 pp).
Extended European Search Report corresponding to EP 13 19 6816.6, completed Mar. 28, 2014 and mailed Apr. 9, 2014; (9 pp).
Extended European Search Report corresponding to EP 13 19 4995.0, completed Jun. 5, 2014 and mailed Jun. 16, 2014; (5 pp).
Extended European Search Report corresponding to EP 13 19 5019.8, completed Mar. 14, 2014 and mailed Mar. 24, 2014; (7 pp).
Extended European Search Report corresponding to EP 13 19 2111.6, completed Feb. 13, 2014 and mailed on Feb. 27, 2014; (10 pp).
Extended European Search Report corresponding to EP 13 19 7958.5, completed Apr. 4, 2014 and mailed Apr. 15, 2014; (8 pp).
Extended European Search Report corresponding to EP 14 15 6342.9, completed Jul. 22, 2014 and mailed Jul. 29, 2014; (8 pp).
Extended European Search Report corresponding to EP 14 15 7195.0, completed Jun. 5, 2014 and mailed Jun. 18, 2014; (9 pp).
Extended European Search Report corresponding to EP 14 16 8904.2, completed Sep. 10, 2014 and mailed Sep. 18, 2014; (8 pp).
Related Publications (1)
Number Date Country
20140084042 A1 Mar 2014 US
Continuations (5)
Number Date Country
Parent 13652502 Oct 2012 US
Child 14093795 US
Parent 13307581 Nov 2011 US
Child 13652502 US
Parent 13051475 Mar 2011 US
Child 13307581 US
Parent 12687400 Jan 2010 US
Child 13051475 US
Parent 11820239 Jun 2007 US
Child 12687400 US